Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
NMDARs activation regulates endothelial ferroptosis via the PP2A-AMPK-HMGB1 axis
Wei-Min Han1,2, Yi-Xiang Hong1,2, Guo-Sheng Xiao3,4
1Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, 361008, China.
Abstract:
N-methyl-D-aspartate receptors (NMDARs) are ligand-gated, voltage-dependent channels of the ionotropic glutamate receptor family. The present study explored whether NMDAR activation induced ferroptosis in vascular endothelial cells and its complicated mechanisms in vivo and in vitro. Various detection approaches were used to determine the ferroptosis-related cellular iron content, lipid reactive oxygen species (LOS), siRNA molecules, RNA-sequence, MDA, GSH, and western blotting. The AMPK activator Acadesine (AICAR), HMGB1 inhibitor glycyrrhizin (GLY), PP2A inhibitor LB-100, and NMDAR inhibitor MK801 were used to investigate the involved in vivo and in vitro pathways. The activation of NMDAR with L-glutamic acid (GLU) or NMDA significantly promoted cellular ferroptosis, iron content, MDA, and the PTGS2 expression, while decreasing GPX4 expression and GSH concentration in human umbilical vein endothelial cells (HUVECs), which was reversed by ferroptosis inhibitors Ferrostatin-1(Fer-1), Liproxstatin-1 (Lip-1), or Deferoxamine (DFO). RNA-seq revealed that ferroptosis and SLC7A11 participate in NMDA or GLU-mediated NMDAR activation. The PP2A-AMPK-HMGB1 pathway was majorly associated with NMDAR activation-induced ferroptosis, validated using the PP2A inhibitor LB-100, AMPK activator AICAR, or HMGB1 siRNA. The role of NMDAR in ferroptosis was validated in HUVECs induced with the ferroptosis activator errasin or RSL3 and counteracted by the NMDAR inhibitor MK-801. The in vivo results showed that NMDA- or GLU-induced ferroptosis and LOS production was reversed by MK-801, LB-100, AICAR, MK-801, and GLY, confirming that the PP2A-AMPK-HMGB1 pathway is involved in NMDAR activation-induced vascular endothelium ferroptosis. In conclusion, the present study demonstrated a novel role of NMDAR in endothelial cell injury by regulating ferroptosis via the PP2A-AMPK-HMGB1 pathway.
Insights
N-methyl-D-aspartate receptors (NMDARs) trigger ferroptosis in vascular endothelial cells. This cell death is regulated by the PP2A-AMPK-HMGB1 pathway, offering new insights into endothelial cell injury mechanisms.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- N-methyl-D-aspartate receptors (NMDARs) are critical ionotropic glutamate receptors involved in synaptic plasticity and neuronal function.
- Ferroptosis is a regulated form of cell death characterized by iron accumulation and lipid peroxidation, implicated in various pathologies.
- Vascular endothelial cells play a crucial role in maintaining vascular integrity and are susceptible to various forms of injury.
Purpose of the Study:
- To investigate whether NMDAR activation induces ferroptosis in vascular endothelial cells.
- To elucidate the underlying molecular mechanisms, including specific signaling pathways involved in NMDAR-mediated ferroptosis.
- To validate the findings both in vitro using human umbilical vein endothelial cells (HUVECs) and in vivo.
Main Methods:
- Utilized various detection approaches including western blotting, RNA-sequencing, and measurement of cellular iron content, lipid reactive oxygen species (LOS), MDA, and GSH.
- Employed pharmacological inhibitors (MK801, LB-100, glycyrrhizin) and activators (AICAR) to probe signaling pathways.
- Validated findings using ferroptosis inducers (errasin, RSL3) and inhibitors (Ferrostatin-1, Liproxstatin-1, Deferoxamine).
Main Results:
- NMDAR activation with L-glutamic acid (GLU) or NMDA significantly promoted ferroptosis in HUVECs, evidenced by increased iron content, MDA, PTGS2 expression, and decreased GPX4 expression and GSH.
- RNA-sequencing identified ferroptosis and SLC7A11 as key players in NMDA/GLU-mediated NMDAR activation.
- The PP2A-AMPK-HMGB1 pathway was identified as a crucial mediator of NMDAR activation-induced ferroptosis, confirmed through inhibitor and activator studies.
- In vivo studies corroborated that NMDAR activation induces ferroptosis and LOS production, which can be reversed by targeting this pathway.
Conclusions:
- N-methyl-D-aspartate receptor activation is a novel inducer of ferroptosis in vascular endothelial cells.
- The PP2A-AMPK-HMGB1 signaling pathway is critically involved in mediating NMDAR-induced endothelial cell ferroptosis.
- These findings reveal a new mechanism of endothelial cell injury regulated by NMDARs and ferroptosis, with potential therapeutic implications.
More Related Videos
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
PI3K/mTOR/AKT Signaling Pathway
The Unfolded Protein Response
Regulation of Angiogenesis and Blood Supply
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...